Experimental Cures for Fragile Patients: Prenatal Stem Cell and Gene Therapies
In this month's episode, Experimental Cures for Fragile Patients: Prenatal Stem Cell and Gene Therapies, brought to you by The Scientist and sponsored by NanoTemper Technologies, we discuss how scientists develop stem cell and gene therapies to treat life-threatening diseases in utero.
Niki Spahich from The Scientist’s Creative Services team spoke with Amy O’Connell, a neonatologist at Boston Children’s Hospital, and Tippi MacKenzie, a Professor of Surgery at the University of San Francisco Medical School, to learn more.
The Scientist Speaks is a podcast produced by The Scientist’s Creative Services team. Our podcast is by scientists and for scientists. Once a month, we will bring you the stories behind news-worthy molecular biology research.
Amy O’Connell, MD, PhD Division of Newborn Medicine, Boston Children's Hospital
Manton Center for Orphan Disease Research, Boston Children's Hospital Department of Pediatrics, Harvard Medical School
Tippi C. MacKenzie, MD Professor of Surgery
Director of Research, Fetal Treatment Center Co-Director, UCSF Center for Maternal-Fetal Precision Medicine
Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com